Navigation Links
Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents
Date:7/14/2011

ROCKVILLE, Md., July 14, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: "Compositions to Effect Neuronal Growth."  The patents cover three new compounds and include both structure and method claims for inducing neurogenesis and the growth of new neurons, both in-vitro and in-vivo.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

Neuralstem's first neurogenic patented compound is currently in a Phase I FDA-approved safety trial in major depressive disorder. The Phase Ia trial, which is in healthy volunteers, is scheduled to be completed in August. The Phase Ib safety trial in depressed patients is expected to commence this fall.

"These patents cover additional new chemical entities from our neurogenic program and broaden our potential clinical development pipeline," said Karl Johe, Ph.D., Neuralstem Chairman and Chief Scientific Officer.  "Our proprietary neural stem cell technology allows for a unique window into the process of neurogenesis. Through this, we've discovered novel chemical compounds that are truly neurogenic. We believe that our portfolio of neurogenic compounds will be at the forefront of novel treatments for psychiatric and cognitive diseases that focus on neural regeneration, not just brain chemistry."

"This is also an important validation of our screening platform," said Richard Garr, Neuralstem President & CEO. "We are not only able to identify neurogenic and neuroprotective compounds by screening against our cells, but we can also identify novel, patentable compounds, across a diverse chemical library.   As the patents run out across the industry on many CNS drugs, we believe Neuralstem is well-positioned to provide value to our future development partners."  

About
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neuralstem Updates NSI-189 Major Depression Trial
2. Dr. Eva Feldman, Principal Investigator, Presents Interim Safety Results for Neuralstem ALS Trial
3. Neuralstem Updates ALS Clinical Trial Progress
4. Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
5. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
6. Neuralstems Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
7. Neuralstems ALS Trial on Clinical Hold
8. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
9. Neuralstem Announces Issuance of Core Technology Patent in Europe
10. Vapotherm Announces Approval in Canada for New High Flow Device Designed for Heliox
11. Access Pharmaceuticals Announces Restructuring of Outstanding Senior Convertible Note
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... and RALEIGH, N.C., Oct. 20, 2014  BioPontis Alliance ... (HNF), both philanthropies, announced today the creation of ... the treatment of the rare disease known as ... announced its alliance model earlier this month. Today,s ... of a collaborative model where researchers and all ...
(Date:10/19/2014)... SEATTLE, Wash. , Oct. 20, 2014 ... today that it will report its third quarter 2014 ... close of the U.S. financial markets. Following the announcement, ... conference call to discuss the results and provide a ... PDT). Access to the event can be obtained as ...
(Date:10/19/2014)... 19, 2014 Große Pharmafirmen ... Das Problem dabei ist, dass große Pharmafirmen nicht ... zu teilen. Es war deshalb nicht ... uns umso mehr, dass es uns gelungen ist! ... Kühlketten aufzuschreiben - mit einem Vorbehalt - einige ...
Breaking Medicine Technology:The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
... EAST BRUNSWICK, N.J. , April 30 Savient Pharmaceuticals, Inc. (Nasdaq: ... the first quarter 2010 following the close of the market on Wednesday ... , ... Financial Officer, will host an investment community conference call beginning at 10:00 ...
Cached Medicine Technology:BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3Savient Pharmaceuticals To Hold First Quarter 2010 Results 2
(Date:10/20/2014)... T.E.N., a technology and information security ... William H. Murray, renowned author and industry visionary, ... Award winner. Presented annually, the ISE® Luminary Leadership ... and industry practitioner for his or her distinguished ... security industry. , Formerly with IBM, Murray is ...
(Date:10/20/2014)... 2014 JZ Fitness, an independently operated ... wellness programming, authorship, international lecturing and community wellness, created ... the release of the JZ Fitness nutrition app, available ... coaching thousands of individuals on nutrition, Jenn Zerling (“JZ”) ... not require calorie counting or cumbersome food logging. ...
(Date:10/20/2014)... AttorneyOne.com, a recognized authority on law, update ... FDA on Sit and Slim II . , ... or use Sit and Slim II because it contains ... as weight loss product on various websites and possibly in ... 2010 for safety reasons, can significantly increase blood pressure and/or ...
(Date:10/20/2014)... Oregon (PRWEB) October 20, 2014 Succeed is ... of local companies who participated in the Every Body ... is a public awareness project that encourages workers to be ... Summer Step 10,000 Program, which concluded at the end of ... variety of cities and metro areas. Participating companies gave ...
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
Breaking Medicine News(10 mins):Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2
... to Other Food ManufacturersCHICAGO, April 1 Fonterra ... water in New Zealand, called Whole. The product, ... first for the market, and food and beverage ... markets can currently leverage the product,s constituent ingredients. ...
... Largest Independent Online Retailer of Beauty and Skin-Care ... 24 Sandow Media, parent company of ... and Salu Beauty, parent company of SkinStore.com, today ... reach for beauty product manufacturers. This powerful new ...
... HLS ) today announced it will host an investor ... 2009, to discuss its results for the first quarter of ... 406-5369 and giving the pass code 91485741. International callers should ... call approximately 10 minutes before the start of the call ...
... p.m. EDT -- SOUTH SAN FRANCISCO, Calif., April ... ) today announced the execution of a securities purchase ... of up to $43.5 million in a tranched financing, ... stock and common stock warrants, and a tranche of ...
... April 1 Misonix, Inc. (Nasdaq: MSON ... technology, which in Europe is used for the ablation ... has entered into a new, three year, exclusive distribution ... for the distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator ...
... suggests link to modifiable maternal habit, , , WEDNESDAY, April ... infants sleeping on their stomachs as the greatest modifiable ... Australian researchers suggest. , They found that when mothers ... them in response to a life-threatening situation, is altered, ...
Cached Medicine News:Health News:Fonterra's New ClearProtein(TM) Satiety Water a First for New Zealand Market 2Health News:Fonterra's New ClearProtein(TM) Satiety Water a First for New Zealand Market 3Health News:NewBeauty Magazine and SpaLook.com Create Strategic Alliance With Salu Beauty and SkinStore.com 2Health News:NewBeauty Magazine and SpaLook.com Create Strategic Alliance With Salu Beauty and SkinStore.com 3Health News:HealthSouth Announces Date of 2009 First Quarter Earnings Conference Call 2Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 2Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 3Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 4Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 5Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 6Health News:Misonix Announces New Distribution Agreement for Belgium and Luxembourg 2Health News:Misonix Announces New Distribution Agreement for Belgium and Luxembourg 3Health News:Mom's Smoking May Lead to SIDS 2
A quick reference for the diagnosis and treatment of many orthopedic conditions....
The Urinary System Flash Cards product uses the time tested content and images from BryanEdwards.com and displays the necessary images to demonstrate the urinary system....
... all-original guide prepared specifically for ... from "PocketMedicine/Internal Medicine", it will ... those training in the field, ... are frequently the first to ...
Neurology, neurosurgery, and internal medicine residents and practitioners will find this mobile solution an essential reference for their day-to-day practice....
Medicine Products: